Evidence map›Paper›PMID 32665341›Full record

ArticleBMJ open2020

Reliability and validity of the Chinese version of the Patient Health Questionnaire-9 (C-PHQ-9) in patients with psoriasis: a cross-sectional study.

Xin Ye, Hui-Ling Shu, Xia Feng, Deng-Mei Xia, Zheng-Qun Wang, Wen-Yao Mi, Bei Yu, Xue-Li Zhang, Changqiang Li

Erratum issuedAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Xin Ye *Department of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Hui-Ling Shu *Department of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Xia FengDepartment of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Deng-Mei XiaDepartment of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Zheng-Qun WangDepartment of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Wen-Yao MiDepartment of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Bei YuDepartment of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Xue-Li ZhangDepartment of Psychiatry, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Changqiang LiDepartment of Dermatology, Affiliated Hospital of Southwest Medical University, Luzhou, China Lcq-1973@163.com.ORCID 0000-0001-8010-7366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the clinical reliability and validity of the Chinese version of the Patient Health Questionnaire-9 (C-PHQ-9) in patients with psoriasis.

designCross-sectional study.

settingTertiary care centre.

participantsPatients with psoriasis who have not been diagnosed with depression (n=148; mean age 43.37±17.46 years; 31.19% female). PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measures considered in this study were the C-PHQ-9 and the Hamilton Depression Scale (HAMD). The American Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V) was used as the gold standard for the diagnosis of depression. Cronbach's α and test-retest reliability after 1 week were evaluated using reliability analysis, and criterion and structural validity were assessed using validity analysis. Receiver operating characteristic (ROC) analysis was performed to identify the best demarcation score and diagnostic accuracy.

resultsCompared with DSM-V (27.27%), both C-PHQ-9 (39.19%) and HAMD (31.01%) had higher rates for detecting depression. The mean completion time for C-PHQ-9 evaluation (2.02±0.84 min) was significantly less than that for HAMD (23.37±3.21 min, p<0.001). The Cronbach's α coefficient for the C-PHQ-9 was 0.938. The correlation coefficients of the nine items with the total scale ranged from 0.540 to 0.854, and the mean inter-item correlation coefficients ranged from 0.376 to 0.933. After a week, the retest coefficient was 0.955 (p<0.01). Principal component factor analysis showed that C-PHQ-9 identified a unifactorial structure. The best cut-off point was 9 points, with a sensitivity of 98.00% and a specificity of 90.80%. The area under the ROC curve was 0.979 (95% CI 0.968 to 0.991).

conclusionC-PHQ-9 has good reliability and validity in patients with psoriasis and can be used for primary screening of patients with psoriasis and depression. This scale has obvious time and labour advantages over the HAMD and should be considered for use in clinical practice.

Indexed as

Patient Health QuestionnairePsoriasisAdultChinaCross-Sectional StudiesDepressionFemaleHumansMaleMass ScreeningMiddle AgedPsychometricsReproducibility of ResultsSurveys and QuestionnairesC-PHQ-9depressionpsoriasisreliabilityvalidity

Identifiers

PMID32665341
PMCPMC7359185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.